Medicina clinica
-
The aim of this study was to evaluate the efficacy and toxicity of high-dose rituximab (HD-R) in combination with autologous stem cell transplantation (auto-SCT) in patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL). ⋯ HD-R in combination with auto-SCT is a feasible and promising treatment for patients with relapsed or refractory DLBCL.
-
Adequate medication intake affects treatment effectiveness. The aim of this study was to establish the impact of prescription and secondary adherence to beta-blockers on medium- and long-term and long-term cardiovascular outcomes, after a first type 1 ST-elevation myocardial infarction (STEMI) episode without heart failure or left ventricular ejection fraction ≥ 40%. ⋯ Secondary adherence to beta-blockers improves 1-year prognosis after STEMI with preserved left ventricular function.